Table 5. Human biting rate (HBR, bites/person/month), sporozoite index (SI, positive/1000) and entomological inoculation rate (EIR, infective bites/person/month) for primary malaria vectors ( Anopheles minimus, An. maculatu s and An. dirus) by study village according to period before and after mass drug administration (MDA) intervention.
Before MDA ‡ | After MDA | All follow-up | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
n/N | index | 95%CI | n/N | index | 95%CI | n/N | index | 95%CI | ||
A1-KNH | Human.nights | 200 | 850 | 1050 | ||||||
HBR | 1615/6.67 * | 242 | [231-254] | 7803/28.33 * | 275 | [269-282] | 9418/35.00 * | 269 | [264-275] | |
Pf-SI | 3/1574 † | 1.9 | [0.4-5.6] | 1/7307 † | 0.1 | [0.004-0.8] | 4/8881 † | 0.5 | [0.1-1.2] | |
Pf-EIR | 0.46 | [0.01-1.36] | 0.04 | [0.001-0.21] | 0.12 | [0.03-0.31] | ||||
A2-TOT | Human.nights | 150 | 900 | 1050 | ||||||
HBR | 1776/5.00 * | 355 | [339-372] | 22438/30.00 * | 748 | [738-758] | 24214/35.00 * | 692 | [683-701] | |
Pf-SI | 3/1729 † | 1.7 | [0.4-5.1] | 3/20742 † | 0.1 | [0.03-0.4] | 6/22471 † | 0.3 | [0.1-0.6] | |
Pf-EIR | 0.61 | [0.13-1.88] | 0.10 | [0.02-0.30] | 0.17 | [0.07-0.39] | ||||
B1-TPN | Human.nights | 600 | 400 | 1000 | ||||||
HBR | 4500/20.00 * | 225 | [218-232] | 1419/13.33 * | 106 | [101-112] | 5919/33.33 * | 178 | [173-182] | |
Pf-SI | 2/4265 † | 0.5 | [0.1-1.7] | 1/1271 † | 0.8 | [0.02-4.4] | 3/5536 † | 0.5 | [0.1-0.6] | |
Pf-EIR | 0.12 | [0.01-0.38] | 0.08 | [0.002-0.46] | 0.11 | [0.02-0.28] | ||||
B2-HKT | Human.nights | 670 | 350 | 1020 | ||||||
HBR | 6771/22.33 * | 302 | [296-310] | 3870/11.67 * | 332 | [321-342] | 10641/34.00 * | 312 | [307-319] | |
Pf-SI | 5/6632 † | 0.8 | [0.2-1.8] | 0/3809 † | 0 | [0-1] | 5/10441 † | 0.5 | [0.2-1.1] | |
Pf-EIR | 0.21 | [0.07-0.54] | 0 | [0-0.36] | 0.14 | [0.05-0.36] | ||||
4 villages | Human.nights | 1620 | 2500 | 4120 | ||||||
HBR | 14662/54.00 * | 272 | [267-276] | 35530/83.33 * | 426 | [422-431] | 50192/137.33 * | 365 | [362-369] | |
Pf-SI | 13/14200 † | 0.9 | [0.5-1.6] | 5/33129 † | 0.2 | [0.05-0.4] | 18/47329 † | 0.4 | [0.2-0.6] | |
Pf-EIR | 0.25 | [0.13-0.43] | 0.06 | [0.02-0.15] | 0.14 | [0.08-0.22] |
‡ 1 to 2 surveys conducted during MDA intervention are included for each village
* n captured/N person.time exposed (human.months)
† n positive/N tested